Airway centered invasive pulmonary aspergillosis in an immunocompetent patient: case report and literature review.

Invasive pulmonary aspergillosis is a major problem that occurs in severely immunocompromised patients. Airway centered invasive pulmonary aspergillosis is rare in patients with normal immunity or those without critical illness. Computed tomography (CT) is a very useful diagnostic modality, yielding characteristic imaging findings for early diagnosis of this infection in immunocompromised and immunocompetent patients. We describe the case of an immunocompetent patient with airway centered invasive aspergillosis, who was successfully treated with voriconazole.

[1]  J. Rello,et al.  Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes , 2015, Critical Care.

[2]  J. Sohn,et al.  Fatal Clinical Course of Probable Invasive Pulmonary Aspergillosis with Influenza B Infection in an Immunocompetent Patient , 2014, Tuberculosis and respiratory diseases.

[3]  S. Walsh,et al.  Airway and parenchymal manifestations of pulmonary aspergillosis. , 2013, Respiratory medicine.

[4]  Xy Xu,et al.  Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review. , 2013, Journal de mycologie medicale.

[5]  Mi Young Kim,et al.  Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value. , 2011, The Journal of infection.

[6]  E. Grabczak,et al.  Tracheobronchial Manifestations of Aspergillus Infections , 2011, TheScientificWorldJournal.

[7]  A. Soubani,et al.  Pulmonary aspergillosis: a clinical review , 2011, European Respiratory Review.

[8]  J. Goo,et al.  Pulmonary aspergillosis in immunocompetent patients without air-meniscus sign and underlying lung disease: CT findings and histopathologic features , 2011, Acta radiologica.

[9]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  D. Kontoyiannis,et al.  Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. , 2005, Blood.

[11]  R. Guleria,et al.  Invasive Tracheobronchial Aspergillosis in an Immunocompetent Person , 2005, The American journal of the medical sciences.

[12]  N. Müller,et al.  Aspergillus Infection of the Airways: Computed Tomography and Pathologic Findings , 2004, Journal of computer assisted tomography.

[13]  A. Gratwohl,et al.  Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients , 2002, European Respiratory Journal.

[14]  N. Müller,et al.  Invasive aspergillosis of the airways: radiographic, CT, and pathologic findings. , 1994, Radiology.

[15]  P. Desikan,et al.  Unusual cause of chronic cough in an immunocompetent host. , 2009, Journal of Bronchology & Interventional Pulmonology.

[16]  F. Colardyn,et al.  Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. , 2004, Acta clinica Belgica.

[17]  J. Ko,et al.  Pulmonary aspergillosis in an immunocompetent patient. , 2002, Journal of thoracic imaging.